Nexstim

Country:
Finland
Founding year:
2000

Nexstim is a neurotechnology company developing non-invasive brain stimulation and mapping systems based on navigated transcranial magnetic stimulation (nTMS). The company focuses on precise targeting of cortical regions by combining TMS with real-time neuronavigation.

Its platform integrates magnetic stimulation hardware with MRI-guided navigation software to enable accurate functional brain mapping and therapeutic stimulation. These systems are used to localize motor and language areas, support pre-surgical planning, and deliver targeted neuromodulation protocols.

Nexstim’s technology is deployed in hospitals, neurosurgical centers, and research institutions worldwide. The company positions its systems as clinically validated infrastructure for brain mapping and non-invasive neuromodulation rather than consumer or experimental stimulation tools.

Neuromodulation
Therapeutics
Clinical Workflows

Neurofounders Insights

Modality:
TMS
Form Factor:
External device
Interface Depth:
Non-invasive
Indication:
Psychiatry
Target user:
Clinicians
Regulatory stage:
FDA approved (PMA)

Public

Nexstim is a long-standing navigated TMS company, differentiated by image-guided targeting that improves stimulation precision for mapping and therapy. Its public-market presence and procedural maturity place it closer to incumbent neurostimulation infrastructure than startup experimentation.

Related companies

Articles featuring

Nexstim

No articles yet!

Press releases

No press releases published yet.